Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE · · 2 pages · English
Summary by 6ix AI
It confirms the handling of securities received for dematerialization during the specified quarter and their subsequent listing on stock exchanges. The filing includes a request for the BSE to take note of the compliance details provided.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Titan Biotech
- Titan Biotech Limited Press Release Mar 26 2026
- Closure of Trading Window
- Titan Biotech Limited Press Release Feb 13 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2025
Later from Titan Biotech
- Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Titan Biotech Limited Press Release Apr 06 2026
- Titan Biotech Limited Press Release Apr 23 2026
- Titan Biotech Limited Press Release Apr 28 2026
- Titan Biotech Limited Press Release May 06 2026
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech